Last reviewed · How we verify

NCT03945071

The Effect of Punctal Plugs on Ocular Surface After Povidone-Iodine Preparation of Intravitreal Injection

Completed NA Last updated 7 December 2023
What this trial tests

NA trial testing Punctal plug in Dry Eye Syndromes in 126 participants. Completed in 18 October 2020.

Timeline
1 June 2019
Primary endpoint
18 October 2020
18 October 2020

Quick facts

Lead sponsorUniversity of Oklahoma
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment126
Start date1 June 2019
Primary completion18 October 2020
Estimated completion18 October 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Oklahoma

Who can join

18 and older, any sex, with Dry Eye Syndromes or Dry Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effectiveness of punctal plugs in reducing ocular surface (eye surface) irritation after intravitreal injections prepared by povidone-iodine 5% solution.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of punctal plugs in reducing ocular surface irritation after povidone-iodine preparation of intravitreal injection-a randomized trial.
    Jin HD, Surbeck JW, Marsh HR, Ding K, et al · · 2022 · cited 6× · PMID 33746207 · DOI 10.1038/s41433-021-01476-3

Verify or expand the search:

Other trials of Punctal plug

Trials testing the same drug.

Other recruiting trials for Dry Eye Syndromes

Currently open trials in the same condition.

Other University of Oklahoma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03945071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing